A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group. [electronic resource]
Producer: 19901106Description: S28-32 p. digitalISSN:- 0959-8049
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Chlorpromazine -- therapeutic use
- Dexamethasone -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Granisetron
- Humans
- Indazoles -- therapeutic use
- Male
- Middle Aged
- Serotonin Antagonists -- therapeutic use
- Time Factors
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.